Merck Sharp & Dohme appeals judgment tossing Januvia patent extension

Intellectual Property 2021-09-10 6:04 pm By Miklos Bolza | Sydney

Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.